[1]
“DEVELOPMENT AND EVALUATION OF SBA-15 MESOPOROUS SILICA NANOPARTICLES FOR BIOAVAILABILITY ENHANCEMENT OF RITONAVIR”, Int. Res. J. Pharm., vol. 9, no. 3, pp. 13–19, Mar. 2018, Accessed: Oct. 31, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/808